ALKS
Price
$24.44
Change
-$0.21 (-0.85%)
Updated
Apr 25, 6:59 PM EST
6 days until earnings call
ANIP
Price
$64.95
Change
-$0.48 (-0.73%)
Updated
Apr 25, 6:59 PM EST
15 days until earnings call
Ad is loading...

Compare trend and price ALKS vs ANIP

Header iconALKS vs ANIP Comparison
Open Charts ALKS vs ANIPBanner chart's image
Alkermes
Price$24.44
Change-$0.21 (-0.85%)
Volume$733.72K
CapitalizationN/A
ANI Pharmaceuticals
Price$64.95
Change-$0.48 (-0.73%)
Volume$29.97K
CapitalizationN/A
View a ticker or compare two or three
ALKS vs ANIP Comparison Chart

Loading...

ALKSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
ANIPDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ALKS vs. ANIP commentary
Apr 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALKS is a Hold and ANIP is a Hold.

COMPARISON
Comparison
Apr 26, 2024
Stock price -- (ALKS: $24.65 vs. ANIP: $65.43)
Brand notoriety: ALKS and ANIP are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALKS: 86% vs. ANIP: 50%
Market capitalization -- ALKS: $4.55B vs. ANIP: $1.43B
ALKS [@Pharmaceuticals: Other] is valued at $4.55B. ANIP’s [@Pharmaceuticals: Other] market capitalization is $1.43B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALKS’s FA Score shows that 1 FA rating(s) are green whileANIP’s FA Score has 0 green FA rating(s).

  • ALKS’s FA Score: 1 green, 4 red.
  • ANIP’s FA Score: 0 green, 5 red.
According to our system of comparison, ALKS is a better buy in the long-term than ANIP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALKS’s TA Score shows that 5 TA indicator(s) are bullish while ANIP’s TA Score has 3 bullish TA indicator(s).

  • ALKS’s TA Score: 5 bullish, 3 bearish.
  • ANIP’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ALKS is a better buy in the short-term than ANIP.

Price Growth

ALKS (@Pharmaceuticals: Other) experienced а +2.67% price change this week, while ANIP (@Pharmaceuticals: Other) price change was -0.08% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.10%. For the same industry, the average monthly price growth was +25.87%, and the average quarterly price growth was +18903.10%.

Reported Earning Dates

ALKS is expected to report earnings on Jul 24, 2024.

ANIP is expected to report earnings on Aug 07, 2024.

Industries' Descriptions

@Pharmaceuticals: Other (-2.10% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
A.I.dvisor published
a Summary for ALKS with price predictions.
OPEN
A.I.dvisor published
a Summary for ANIP with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ALKS($4.55B) has a higher market cap than ANIP($1.43B). ANIP has higher P/E ratio than ALKS: ANIP (79.85) vs ALKS (8.90). ANIP YTD gains are higher at: 18.662 vs. ALKS (-11.139). ALKS has higher annual earnings (EBITDA): 519M vs. ANIP (107M). ALKS has more cash in the bank: 773M vs. ANIP (221M). ANIP has less debt than ALKS: ANIP (286M) vs ALKS (372M). ALKS has higher revenues than ANIP: ALKS (1.66B) vs ANIP (487M).
ALKSANIPALKS / ANIP
Capitalization4.55B1.43B318%
EBITDA519M107M485%
Gain YTD-11.13918.662-60%
P/E Ratio8.9079.8511%
Revenue1.66B487M341%
Total Cash773M221M350%
Total Debt372M286M130%
FUNDAMENTALS RATINGS
ALKS vs ANIP: Fundamental Ratings
ALKS
ANIP
OUTLOOK RATING
1..100
1256
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
97
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
3285
PRICE GROWTH RATING
1..100
6243
P/E GROWTH RATING
1..100
9880
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ANIP's Valuation (97) in the Pharmaceuticals Other industry is in the same range as ALKS (99) in the Biotechnology industry. This means that ANIP’s stock grew similarly to ALKS’s over the last 12 months.

ANIP's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as ALKS (100) in the Biotechnology industry. This means that ANIP’s stock grew similarly to ALKS’s over the last 12 months.

ALKS's SMR Rating (32) in the Biotechnology industry is somewhat better than the same rating for ANIP (85) in the Pharmaceuticals Other industry. This means that ALKS’s stock grew somewhat faster than ANIP’s over the last 12 months.

ANIP's Price Growth Rating (43) in the Pharmaceuticals Other industry is in the same range as ALKS (62) in the Biotechnology industry. This means that ANIP’s stock grew similarly to ALKS’s over the last 12 months.

ANIP's P/E Growth Rating (80) in the Pharmaceuticals Other industry is in the same range as ALKS (98) in the Biotechnology industry. This means that ANIP’s stock grew similarly to ALKS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALKSANIP
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
72%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 3 days ago
74%
Declines
ODDS (%)
Bearish Trend 10 days ago
67%
Bearish Trend 8 days ago
70%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
67%
View a ticker or compare two or three
Ad is loading...
ALKSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
ANIPDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSLAX15.260.07
+0.46%
Putnam Small Cap Value A
IOLZX27.85-0.02
-0.07%
ICON Equity Institutional
LADPX17.86-0.10
-0.56%
Lord Abbett Developing Growth P
FGKFX24.74-0.14
-0.56%
Fidelity Growth Company K6
VAIGX17.41-0.15
-0.85%
Vanguard Advice Select Intl Gr Admiral

ALKS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALKS has been loosely correlated with VTRS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ALKS jumps, then VTRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALKS
1D Price
Change %
ALKS100%
+1.61%
VTRS - ALKS
34%
Loosely correlated
+1.67%
ACET - ALKS
30%
Poorly correlated
-10.71%
DCPH - ALKS
28%
Poorly correlated
-0.34%
ITCI - ALKS
26%
Poorly correlated
-1.20%
PAHC - ALKS
25%
Poorly correlated
-7.71%
More

ANIP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIP has been loosely correlated with DRRX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIP jumps, then DRRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIP
1D Price
Change %
ANIP100%
-1.07%
DRRX - ANIP
42%
Loosely correlated
+4.75%
SNDL - ANIP
31%
Poorly correlated
-3.38%
PRPH - ANIP
29%
Poorly correlated
-1.94%
VTRS - ANIP
26%
Poorly correlated
+1.67%
PETQ - ANIP
26%
Poorly correlated
-0.42%
More